Research on development strategies of Xinjiang biomedical industry based on ralational degree and SWOT analysis
Objective To analyze the biopharmaceutical industry in Xinjiang using the grey correlation method,and combine it with SWOT analysis to identify the shortcomings in the development of the biop-harmaceutical industry in Xinjiang and propose targeted reform measures.Methods Based on grey corre-lation degree to analyze the main influencing indicators and degree of correlation that affect the annual out-put value of Xinjiang's pharmaceutical industry.Combining with the SWOT[S(strengths),W(weaknes-ses),O(opportunities),and T(threats)]analysis of the internal and external aspects of Xinjiang's biop-harmaceutical industry,response strategies and suggestions are proposed.Results The grey correlation a-nalysis results show that the main influencing indicators of the correlation between the annual output value of the pharmaceutical industry from high to low are the number of patent applications,the number of new product development projects,national and regional characteristics personnel,the number of enterprises,national and regional characteristics funds,total profit,and the number of national and regional character-istics institutions.The advantages of Xinjiang's pharmaceutical industry mainly include natural resource advantages,core location advantages,and ethnic and regional characteristics;The main disadvantage is that the top-level design and overall layout of the development of Xinjiang's biopharmaceutical industry chain are not clear,the existing industrial foundation is relatively weak,and the ability of technology to support industrial development needs to be improved.In the new stage of development,the geographical advantages of the core area of the Silk Road Economic Belt and the overall layout of the country's opening-up to the west have created a good environment for the development of Xinjiang's pharmaceutical industry.However,the competition in the biopharmaceutical industry is fierce,and the regulatory capacity for drug safety still cannot keep up with the pace of industrial development.Opportunities,challenges,and threats coexist.Conclusions Further high-quality development of Xinjiang's biomedical industry should focus on the levels of technological innovation,industrial layout and policy.
NETL
NSTL
万方数据
